Stay updated with breaking news from Predictive Immune Modeling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cofactor Genomics, a predictive immune modeling company, today presented initial results from the multi-center clinical study PREDAPT (Predicting
(0) San Francisco, California--(Newsfile Corp. - April 13, 2021) - Cofactor Genomics, the company bridging the precision medicine gap, today announced commencement of the first multicenter clinical trial of its OncoPrismTM diagnostic assay, using the company's patented approach to generating multidimensional immune biomarkers. Fifteen hospitals and healthcare networks, including Mayo Clinic, MultiCare Institute for Research and Innovation, and Revive Research Institute, are currently enrolling in the PREDAPT (Predicting Immunotherapy Efficacy From Analysis of Pre-treatment Tumor Biopsies)...